Anne Eaton, PhD, MS

Assistant Professor, Division of Biostatistics

Anne Eaton

Contact Info

Office Phone 612-624-4655

Office Address:
Mayo A448

Mailing Address:
420 Delaware St SE
MMC 303 Mayo
Minneapolis, MN 55455

PhD, Biostatistics, University of Minnesota, 2020

MS, Biostatistics, University of Minnesota, 2010

BA, Mathematics, Grinnell College, 2008


I develop statistical methods to understand processes happening over time that cannot be observed completely due to complex observation and/or censoring processes. My work is driven by common issues arising in cancer research, including multiple related time-to-event endpoints and data collection schedules that differ across patients. In my methodological and collaborative work, I strive to translate data into information that is meaningful to researchers, doctors and patients.


Survival analysis, multistate models, non-parametric methods, clinical trial design

Awards & Recognition

Delta Omega, Honorary Society in Public Health, 2020

Professional Associations

American Statistical Association



See my full list of publications:

Eaton, A. A., Therneau, T., and Le-Rademacher, J. (2020). Designing Clinical Trials with (Restricted) Mean Survival Time Endpoint – Practical Considerations. Clin Trials

Kotalik, A., Eaton, A. A., Lian, Q., Serrano, C., Connett, J., and Neaton, J. D. (2019). A Win Ratio Approach to the Re-Analysis of Multiple Risk Factor Intervention Trial. Clin Trials, 16(6):626–634

Eaton, A. A., Karanicolas, P., Johnson, C., Bottomley, A., Allen, P., and Gonen, M. (2017). Psycho- metric Validation of the EORTC QLQ-PAN26 Pancreatic Cancer Module for Assessing Health Related Quality of Life after Pancreatic Resection. JOP, 18(1):19–25

Eaton, A. A., Gonen, M., Karanicolas, P., Jarnagin, W. R., D’Angelica, M. I., DeMatteo, R., Kingham, T. P., and Allen, P. J. (2016). Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial. Ann. Surg. Oncol., 23(7):2137–2145

Eaton, A. A., Sima, C. S., and Panageas, K. S. (2016). Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data. J Natl Compr Canc Netw, 14(1):57–65

Eaton, A. A., Iasonos, A., Gounder, M. M., Pamer, E. G., Drilon, A., Vulih, D., Smith, G. L., Ivy, S. P., Spriggs, D. R., and Hyman, D. M. (2016). Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities. Clin. Cancer Res., 22(3):553–559


Teaching Areas

I teach in the Biostatistics (MPH, MS, PhD) program.